Error | ValueSet.version | Values for version differ: '0.1.0' vs '0.2.0' |
Information | ValueSet.status | Values for status differ: 'active' vs 'draft' |
Information | ValueSet.date | Values for date differ: '2023-01-26T09:50:21+01:00' vs '2024-09-11T13:25:13+00:00' |
Warning | ValueSet.compose.exclude[0].concept[118] | Code L01XE04 display changed from 'Sunitinib ' to 'Sunitinib' |
Warning | ValueSet.compose.exclude[0].concept[119] | Code L01XE05 display changed from 'Sorafenib ' to 'Sorafenib' |
Warning | ValueSet.compose.exclude[0].concept[233] | Code L03AB01 display changed from 'Interferon alfa natural ' to 'Interferon alfa natural' |
Warning | ValueSet.compose.exclude[0].concept[234] | Code L03AB02 display changed from 'Interferon beta natural ' to 'Interferon beta natural' |
Warning | ValueSet.compose.exclude[0].concept[236] | Code L03AB04 display changed from 'Interferon alfa-2a ' to 'Interferon alfa-2a' |
Warning | ValueSet.compose.exclude[0].concept[237] | Code L03AB05 display changed from 'Interferon alfa-2b ' to 'Interferon alfa-2b' |
Warning | ValueSet.compose.exclude[0].concept[238] | Code L03AB06 display changed from 'Interferon alfa-n1 ' to 'Interferon alfa-n1' |
Warning | ValueSet.compose.exclude[0].concept[239] | Code L03AB07 display changed from 'Interferon beta-1a ' to 'Interferon beta-1a' |
Warning | ValueSet.compose.exclude[0].concept[240] | Code L03AB08 display changed from 'Interferon beta-1b ' to 'Interferon beta-1b' |
Warning | ValueSet.compose.exclude[0].concept[241] | Code L03AB09 display changed from 'Interferon alfacon-1 ' to 'Interferon alfacon-1' |
Warning | ValueSet.compose.exclude[0].concept[242] | Code L03AB10 display changed from 'Peginterferon alfa-2b ' to 'Peginterferon alfa-2b' |
Warning | ValueSet.compose.exclude[0].concept[243] | Code L03AB11 display changed from 'Peginterferon alfa-2a ' to 'Peginterferon alfa-2a' |
Warning | ValueSet.compose.exclude[0].concept[244] | Code L03AB12 display changed from 'Albinterferon alfa-2b ' to 'Albinterferon alfa-2b' |
Warning | ValueSet.compose.exclude[0].concept[245] | Code L03AB13 display changed from 'Peginterferon beta-1a ' to 'Peginterferon beta-1a' |
Warning | ValueSet.compose.exclude[0].concept[246] | Code L03AB14 display changed from 'Cepeginterferon alfa-2b ' to 'Cepeginterferon alfa-2b' |
Warning | ValueSet.compose.exclude[0].concept[251] | Code L03AC02 display changed from 'Oprelvekin ' to 'Oprelvekin' |
Warning | ValueSet.compose.exclude[0].concept[252] | Code L03AX01 display changed from 'Lentinan ' to 'Lentinan' |
Warning | ValueSet.compose.exclude[0].concept[253] | Code L03AX02 display changed from 'Roquinimex ' to 'Roquinimex' |
Warning | ValueSet.compose.exclude[0].concept[255] | Code L03AX04 display changed from 'Pegademase ' to 'Pegademase' |
Warning | ValueSet.compose.exclude[0].concept[256] | Code L03AX05 display changed from 'Pidotimod ' to 'Pidotimod' |
Warning | ValueSet.compose.exclude[0].concept[257] | Code L03AX07 display changed from 'Poly I:C ' to 'Poly I:C' |
Warning | ValueSet.compose.exclude[0].concept[258] | Code L03AX08 display changed from 'Poly ICLC ' to 'Poly ICLC' |
Warning | ValueSet.compose.exclude[0].concept[259] | Code L03AX09 display changed from 'Thymopentin ' to 'Thymopentin' |
Warning | ValueSet.compose.exclude[0].concept[261] | Code L03AX11 display changed from 'Tasonermin ' to 'Tasonermin' |
Warning | ValueSet.compose.exclude[0].concept[262] | Code L03AX12 display changed from 'Melanoma vaccine ' to 'Melanoma vaccine' |
Warning | ValueSet.compose.exclude[0].concept[263] | Code L03AX13 display changed from 'Glatiramer acetate ' to 'Glatiramer acetate' |
Warning | ValueSet.compose.exclude[0].concept[264] | Code L03AX14 display changed from 'Histamine dihydrochloride ' to 'Histamine dihydrochloride' |
Warning | ValueSet.compose.exclude[0].concept[265] | Code L03AX15 display changed from 'Mifamurtide ' to 'Mifamurtide' |
Warning | ValueSet.compose.exclude[0].concept[266] | Code L03AX16 display changed from 'Plerixafor ' to 'Plerixafor' |
Warning | ValueSet.compose.exclude[0].concept[267] | Code L03AX17 display changed from 'Sipuleucel-T ' to 'Sipuleucel-T' |
Warning | ValueSet.compose.exclude[0].concept[268] | Code L03AX18 display changed from 'Cridanimod ' to 'Cridanimod' |
Warning | ValueSet.compose.exclude[0].concept[269] | Code L03AX19 display changed from 'Dasiprotimut-T ' to 'Dasiprotimut-T' |
Name | Value | Comments | |
---|---|---|---|
compose.inactive | |||
compose.lockedDate | |||
copyright | |||
date | 2023-01-26T09:50:21+01:00 | 2024-09-11T13:25:13+00:00 |
|
description | List of WHO ATC codes for antineoplastic and immunostimulating agents. | ||
experimental | false | ||
immutable | |||
jurisdiction | |||
jurisdiction[0] | http://unstats.un.org/unsd/methods/m49/m49.htm#150 | ||
name | VsPcspAtcCodes | ||
publisher | PanCareSurPass Project | ||
purpose | |||
status | active | draft |
|
title | Antineoplastic and immunostimulating agents | ||
url | http://hl7.eu/fhir/ig/pcsp/ValueSet/drugsAtc-eu-pcsp | ||
version | 0.1.0 | 0.2.0 |
|
Item | Property | Value | Comments | ||
---|---|---|---|---|---|
include | http://www.whocc.no/atc | ||||
Concept | L01AA01 | Cyclophosphamide | |||
Concept | L01AA02 | Chlorambucil | |||
Concept | L01AA03 | Melphalan | |||
Concept | L01AA05 | Chlormethine | |||
Concept | L01AA06 | Ifosfamide | |||
Concept | L01AA07 | Trofosfamide | |||
Concept | L01AA08 | Prednimustine | |||
Concept | L01AA09 | Bendamustine | |||
Concept | L01AB01 | Busulfan | |||
Concept | L01AB02 | Treosulfan | |||
Concept | L01AB03 | Mannosulfan | |||
Concept | L01AC01 | Thiotepa | |||
Concept | L01AC02 | Triaziquone | |||
Concept | L01AC03 | Carboquone | |||
Concept | L01AD01 | Carmustine | |||
Concept | L01AD02 | Lomustine | |||
Concept | L01AD03 | Semustine | |||
Concept | L01AD04 | Streptozocin | |||
Concept | L01AD05 | Fotemustine | |||
Concept | L01AD06 | Nimustine | |||
Concept | L01AD07 | Ranimustine | |||
Concept | L01AG01 | Etoglucid | |||
Concept | L01AX | Peptichemio | |||
Concept | L01AX01 | Mitobronitol | |||
Concept | L01AX02 | Pipobroman | |||
Concept | L01AX03 | Temozolomide | |||
Concept | L01AX04 | Dacarbazine | |||
Concept | L01BA01 | Methotrexate | |||
Concept | L01BA03 | Raltitrexed | |||
Concept | L01BA04 | Pemetrexed | |||
Concept | L01BA05 | Pralatrexate | |||
Concept | L01BB02 | Mercaptopurine | |||
Concept | L01BB03 | Thioguanine | |||
Concept | L01BB04 | Cladribine | |||
Concept | L01BB05 | Fludarabine | |||
Concept | L01BB06 | Clofarabine | |||
Concept | L01BB07 | Nelarabine | |||
Concept | L01BC01 | Cytarabine | |||
Concept | L01BC02 | Fluorouracil | |||
Concept | L01BC03 | Tegafur | |||
Concept | L01BC04 | Carmofur | |||
Concept | L01BC05 | Gemcitabine | |||
Concept | L01BC06 | Capecitabine | |||
Concept | L01BC07 | Azacitidine | |||
Concept | L01BC08 | Decitabine | |||
Concept | L01BC52 | Fluorouracil, combinations | |||
Concept | L01BC53 | Tegafur, combinations | |||
Concept | L01BC59 | Trifluridine, combinations | |||
Concept | L01CA01 | Vinblastine | |||
Concept | L01CA02 | Vincristine | |||
Concept | L01CA03 | Vindesine | |||
Concept | L01CA04 | Vinorelbine | |||
Concept | L01CA05 | Vinflunine | |||
Concept | L01CA06 | Vintafolide | |||
Concept | L01CB01 | Etoposide | |||
Concept | L01CB02 | Teniposide | |||
Concept | L01CC01 | Demecolcine | |||
Concept | L01CD01 | Paclitaxel | |||
Concept | L01CD02 | Docetaxel | |||
Concept | L01CD03 | Paclitaxel poliglumex | |||
Concept | L01CD04 | Cabazitaxel | |||
Concept | L01CX01 | Trabectedin | |||
Concept | L01DA01 | Dactinomycin | |||
Concept | L01DB01 | Doxorubicin | |||
Concept | L01DB02 | Daunorubicin | |||
Concept | L01DB03 | Epirubicin | |||
Concept | L01DB04 | Aclarubicin | |||
Concept | L01DB05 | Zorubicin | |||
Concept | L01DB06 | Idarubicin | |||
Concept | L01DB07 | Mitoxantrone | |||
Concept | L01DB08 | Pirarubicin | |||
Concept | L01DB09 | Valrubicin | |||
Concept | L01DB10 | Amrubicin | |||
Concept | L01DB11 | Pixantrone | |||
Concept | L01DC01 | Bleomycin | |||
Concept | L01DC02 | Mithramycin | |||
Concept | L01DC03 | Mitomycin | |||
Concept | L01DC04 | Ixabepilone | |||
Concept | L01XA01 | Cisplatin | |||
Concept | L01XA02 | Carboplatin | |||
Concept | L01XA03 | Oxaliplatin | |||
Concept | L01XA04 | Satraplatin | |||
Concept | L01XA05 | Polyplatillen | |||
Concept | L01XB01 | Procarbazine | |||
Concept | L01XC01 | Edrecolomab | |||
Concept | L01XC02 | Rituximab | |||
Concept | L01XC03 | Trastuzumab | |||
Concept | L01XC04 | Alemtuzumab | |||
Concept | L01XC05 | Gemtuzumab | |||
Concept | L01XC06 | Cetuximab | |||
Concept | L01XC07 | Bevacizumab | |||
Concept | L01XC08 | Panitumumab | |||
Concept | L01XC09 | Catumaxomab | |||
Concept | L01XC10 | Ofatumumab | |||
Concept | L01XC11 | Ipilimumab | |||
Concept | L01XC12 | Brentuximab vedotin | |||
Concept | L01XC13 | Pertuzumab | |||
Concept | L01XC14 | Trastuzumab emtansine | |||
Concept | L01XC15 | Obinutuzumab | |||
Concept | L01XC16 | Dinutuximab | |||
Concept | L01XC17 | Nivolumab | |||
Concept | L01XC18 | Pembrolizumab | |||
Concept | L01XC19 | Blinatumomab | |||
Concept | L01XC21 | Ramucirumab | |||
Concept | L01XC22 | Necitumumab | |||
Concept | L01XC23 | Elotuzumab | |||
Concept | L01XC24 | Daratumumab | |||
Concept | L01XC25 | Mogamulizumab | |||
Concept | L01XC26 | Inotuzumab ozogamicin | |||
Concept | L01XC27 | Olaratumab | |||
Concept | L01XD01 | Porfimer sodium | |||
Concept | L01XD03 | Methyl aminolevulinate | |||
Concept | L01XD04 | Aminolevulinic acid | |||
Concept | L01XD05 | Temoporfin | |||
Concept | L01XD06 | Efaproxiral | |||
Concept | L01XE01 | Imatinib | |||
Concept | L01XE02 | Gefitinib | |||
Concept | L01XE03 | Erlotinib | |||
Concept | L01XE04 | Sunitinib | Sunitinib | ||
Concept | L01XE05 | Sorafenib | Sorafenib | ||
Concept | L01XE06 | Dasatinib | |||
Concept | L01XE07 | Lapatinib | |||
Concept | L01XE08 | Nilotinib | |||
Concept | L01XE09 | Temsirolimus | |||
Concept | L01XE10 | Everolimus | |||
Concept | L01XE11 | Pazopanib | |||
Concept | L01XE12 | Vandetanib | |||
Concept | L01XE13 | Afatinib | |||
Concept | L01XE14 | Bosutinib | |||
Concept | L01XE15 | Vemurafenib | |||
Concept | L01XE16 | Crizotinib | |||
Concept | L01XE17 | Axitinib | |||
Concept | L01XE18 | Ruxolitinib | |||
Concept | L01XE19 | Ridaforolimus | |||
Concept | L01XE21 | Regorafenib | |||
Concept | L01XE22 | Masitinib | |||
Concept | L01XE23 | Dabrafenib | |||
Concept | L01XE24 | Ponatinib | |||
Concept | L01XE25 | Trametinib | |||
Concept | L01XE26 | Cabozantinib | |||
Concept | L01XE27 | Ibrutinib | |||
Concept | L01XE28 | Ceritinib | |||
Concept | L01XE29 | Lenvatinib | |||
Concept | L01XE31 | Nintedanib | |||
Concept | L01XE32 | Cediranib | |||
Concept | L01XE33 | Palbociclib | |||
Concept | L01XE34 | Tivozanib | |||
Concept | L01XE35 | Osimertinib | |||
Concept | L01XE36 | Alectinib | |||
Concept | L01XE37 | Rociletinib | |||
Concept | L01XE38 | Cobimetinib | |||
Concept | L01XE39 | Midostaurin | |||
Concept | L01XE40 | Olmutinib | |||
Concept | L01XX | Other antineoplastic agent | |||
Concept | L01XX01 | Amsacrine | |||
Concept | L01XX02 | Asparaginase | |||
Concept | L01XX03 | Altretamine | |||
Concept | L01XX05 | Hydroxycarbamide | |||
Concept | L01XX07 | Lonidamine | |||
Concept | L01XX08 | Pentostatin | |||
Concept | L01XX09 | Miltefosine | |||
Concept | L01XX10 | Masoprocol | |||
Concept | L01XX11 | Estramustine | |||
Concept | L01XX14 | Tretinoin | |||
Concept | L01XX16 | Mitoguazone | |||
Concept | L01XX17 | Topotecan | |||
Concept | L01XX18 | Tiazofurine | |||
Concept | L01XX19 | Irinotecan | |||
Concept | L01XX22 | Alitretinoin | |||
Concept | L01XX23 | Mitotane | |||
Concept | L01XX24 | Pegaspargase | |||
Concept | L01XX25 | Bexarotene | |||
Concept | L01XX27 | Arsenic trioxide | |||
Concept | L01XX29 | Denileukin diftitox | |||
Concept | L01XX32 | Bortezomib | |||
Concept | L01XX33 | Celecoxib | |||
Concept | L01XX35 | Anagrelide | |||
Concept | L01XX36 | Oblimersen | |||
Concept | L01XX37 | Sitimagene ceradenovec | |||
Concept | L01XX38 | Vorinostat | |||
Concept | L01XX39 | Romidepsin | |||
Concept | L01XX40 | Omacetaxine mepesuccinate | |||
Concept | L01XX41 | Eribulin | |||
Concept | L01XX42 | Panobinostat | |||
Concept | L01XX43 | Vismodegib | |||
Concept | L01XX44 | Aflibercept | |||
Concept | L01XX45 | Carfilzomib | |||
Concept | L01XX46 | Olaparib | |||
Concept | L01XX47 | Idelalisib | |||
Concept | L01XX48 | Sonidegib | |||
Concept | L01XX49 | Belinostat | |||
Concept | L01XX50 | Ixazomib | |||
Concept | L01XX51 | Talimogene laherparepvec | |||
Concept | L01XX52 | Venetoclax | |||
Concept | L01XX53 | Vosaroxin | |||
Concept | L01XY | Combination of antineoplastic agents | |||
Concept | L02AA01 | Diethylstilbestrol | |||
Concept | L02AA02 | Polyestradiol phosphate | |||
Concept | L02AA03 | Ethinylestradiol | |||
Concept | L02AA04 | Fosfestrol | |||
Concept | L02AB01 | Megestrol | |||
Concept | L02AB02 | Medroxyprogesterone | |||
Concept | L02AB03 | Gestonorone | |||
Concept | L02AE01 | Buserelin | |||
Concept | L02AE02 | Leuprorelin | |||
Concept | L02AE03 | Goserelin | |||
Concept | L02AE04 | Triptorelin | |||
Concept | L02AE05 | Histrelin | |||
Concept | L02BA01 | Tamoxifen | |||
Concept | L02BA02 | Toremifene | |||
Concept | L02BA03 | Fulvestrant | |||
Concept | L02BB01 | Flutamide | |||
Concept | L02BB02 | Nilutamide | |||
Concept | L02BB03 | Bicalutamide | |||
Concept | L02BB04 | Enzalutamide | |||
Concept | L02BG01 | Aminogluthetimide | |||
Concept | L02BG02 | Formestane | |||
Concept | L02BG03 | Anastrozole | |||
Concept | L02BG04 | Letrozole | |||
Concept | L02BG05 | Vorozole | |||
Concept | L02BG06 | Exemestane | |||
Concept | L02BX01 | Abarelix | |||
Concept | L02BX02 | Degarelix | |||
Concept | L02BX03 | Abiraterone | |||
Concept | L03AA02 | Filgrastim | |||
Concept | L03AA03 | Molgramostim | |||
Concept | L03AA09 | Sargramostim | |||
Concept | L03AA10 | Lenograstim | |||
Concept | L03AA12 | Ancestim | |||
Concept | L03AA13 | Pegfilgrastim | |||
Concept | L03AA14 | Lipegfilgrastim | |||
Concept | L03AA15 | Balugrastim | |||
Concept | L03AA16 | Empegfilgrastim | |||
Concept | L03AB01 | Interferon alfa natural | Interferon alfa natural | ||
Concept | L03AB02 | Interferon beta natural | Interferon beta natural | ||
Concept | L03AB03 | Interferon gamma | |||
Concept | L03AB04 | Interferon alfa-2a | Interferon alfa-2a | ||
Concept | L03AB05 | Interferon alfa-2b | Interferon alfa-2b | ||
Concept | L03AB06 | Interferon alfa-n1 | Interferon alfa-n1 | ||
Concept | L03AB07 | Interferon beta-1a | Interferon beta-1a | ||
Concept | L03AB08 | Interferon beta-1b | Interferon beta-1b | ||
Concept | L03AB09 | Interferon alfacon-1 | Interferon alfacon-1 | ||
Concept | L03AB10 | Peginterferon alfa-2b | Peginterferon alfa-2b | ||
Concept | L03AB11 | Peginterferon alfa-2a | Peginterferon alfa-2a | ||
Concept | L03AB12 | Albinterferon alfa-2b | Albinterferon alfa-2b | ||
Concept | L03AB13 | Peginterferon beta-1a | Peginterferon beta-1a | ||
Concept | L03AB14 | Cepeginterferon alfa-2b | Cepeginterferon alfa-2b | ||
Concept | L03AB60 | Peginterferon alfa-2b, combinations | |||
Concept | L03AB61 | Peginterferon alfa-2a, combinations | |||
Concept | L03AB90 | Interferone ricombinante omega di origine felina | |||
Concept | L03AC01 | Aldesleukin | |||
Concept | L03AC02 | Oprelvekin | Oprelvekin | ||
Concept | L03AX01 | Lentinan | Lentinan | ||
Concept | L03AX02 | Roquinimex | Roquinimex | ||
Concept | L03AX03 | BCG vaccine | |||
Concept | L03AX04 | Pegademase | Pegademase | ||
Concept | L03AX05 | Pidotimod | Pidotimod | ||
Concept | L03AX07 | Poly I:C | Poly I:C | ||
Concept | L03AX08 | Poly ICLC | Poly ICLC | ||
Concept | L03AX09 | Thymopentin | Thymopentin | ||
Concept | L03AX10 | Immunocyanin | |||
Concept | L03AX11 | Tasonermin | Tasonermin | ||
Concept | L03AX12 | Melanoma vaccine | Melanoma vaccine | ||
Concept | L03AX13 | Glatiramer acetate | Glatiramer acetate | ||
Concept | L03AX14 | Histamine dihydrochloride | Histamine dihydrochloride | ||
Concept | L03AX15 | Mifamurtide | Mifamurtide | ||
Concept | L03AX16 | Plerixafor | Plerixafor | ||
Concept | L03AX17 | Sipuleucel-T | Sipuleucel-T | ||
Concept | L03AX18 | Cridanimod | Cridanimod | ||
Concept | L03AX19 | Dasiprotimut-T | Dasiprotimut-T | ||
Concept | L04AA02 | Muromonab-CD3 | |||
Concept | L04AA03 | Antilymphocyte immunoglobulin (horse) | |||
Concept | L04AA04 | Antithymocyte immunoglobulin (rabbit) | |||
Concept | L04AA06 | Mycophenolic acid | |||
Concept | L04AA10 | Sirolimus | |||
Concept | L04AA13 | Leflunomide | |||
Concept | L04AA15 | Alefacept | |||
Concept | L04AA18 | Everolimus | |||
Concept | L04AA19 | Gusperimus | |||
Concept | L04AA21 | Efalizumab | |||
Concept | L04AA22 | Abetimus | |||
Concept | L04AA23 | Natalizumab | |||
Concept | L04AA24 | Abatacept | |||
Concept | L04AA25 | Eculizumab | |||
Concept | L04AA26 | Belimumab | |||
Concept | L04AA27 | Fingolimod | |||
Concept | L04AA28 | Belatacept | |||
Concept | L04AA29 | Tofacitinib | |||
Concept | L04AA31 | Teriflunomide | |||
Concept | L04AA32 | Apremilast | |||
Concept | L04AA33 | Vedolizumab | |||
Concept | L04AA34 | Alemtuzumab | |||
Concept | L04AA35 | Begelomab | |||
Concept | L04AA36 | Ocrelizumab | |||
Concept | L04AA37 | Baricitinib | |||
Concept | L04AB01 | Etanercept | |||
Concept | L04AB02 | Infliximab | |||
Concept | L04AB03 | Afelimomab | |||
Concept | L04AB04 | Adalimumab | |||
Concept | L04AB05 | Certolizumab pegol | |||
Concept | L04AB06 | Golimumab | |||
Concept | L04AC01 | Daclizumab | |||
Concept | L04AC02 | Basiliximab | |||
Concept | L04AC03 | Anakinra | |||
Concept | L04AC04 | Rilonacept | |||
Concept | L04AC05 | Ustekinumab | |||
Concept | L04AC06 | Mepolizumab | |||
Concept | L04AC07 | Tocilizumab | |||
Concept | L04AC08 | Canakinumab | |||
Concept | L04AC09 | Briakinumab | |||
Concept | L04AC10 | Secukinumab | |||
Concept | L04AC11 | Siltuximab | |||
Concept | L04AC12 | Brodalumab | |||
Concept | L04AC13 | Ixekizumab | |||
Concept | L04AC14 | Sarilumab | |||
Concept | L04AD01 | Ciclosporin | |||
Concept | L04AD02 | Tacrolimus | |||
Concept | L04AD03 | Voclosporin | |||
Concept | L04AX01 | Azathioprine | |||
Concept | L04AX02 | Thalidomide | |||
Concept | L04AX03 | Methotrexate | |||
Concept | L04AX04 | Lenalidomide | |||
Concept | L04AX05 | Pirfenidone | |||
Concept | L04AX06 | Pomalidomide |
Unable to generate expansion - see errors